- Home
- MKSI vs CORT Comparison
MKSI vs CORT Comparison
Compare MKSI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- CORT
- Stock Information
- Founded
- MKSI 1961
- CORT 1998
- Country
- MKSI United States
- CORT United States
- Employees
- MKSI N/A
- CORT N/A
- Industry
- MKSI Industrial Machinery/Components
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MKSI Industrials
- CORT Health Care
- Exchange
- MKSI Nasdaq
- CORT Nasdaq
- Market Cap
- MKSI 7.1B
- CORT 7.6B
- IPO Year
- MKSI 1999
- CORT N/A
- Fundamental
- Price
- MKSI $116.38
- CORT $69.53
- Analyst Decision
- MKSI Buy
- CORT Strong Buy
- Analyst Count
- MKSI 10
- CORT 4
- Target Price
- MKSI $121.70
- CORT $139.00
- AVG Volume (30 Days)
- MKSI 951.1K
- CORT 644.6K
- Earning Date
- MKSI 11-05-2025
- CORT 10-29-2025
- Dividend Yield
- MKSI 0.76%
- CORT N/A
- EPS Growth
- MKSI 3206.74
- CORT N/A
- EPS
- MKSI 3.95
- CORT 1.11
- Revenue
- MKSI $3,741,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- MKSI $8.76
- CORT $30.62
- Revenue Next Year
- MKSI $5.74
- CORT $37.68
- P/E Ratio
- MKSI $29.49
- CORT $62.97
- Revenue Growth
- MKSI 4.50
- CORT 25.71
- 52 Week Low
- MKSI $54.84
- CORT $37.82
- 52 Week High
- MKSI $125.33
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MKSI 68.83
- CORT 45.26
- Support Level
- MKSI $97.50
- CORT $67.32
- Resistance Level
- MKSI $102.45
- CORT $74.79
- Average True Range (ATR)
- MKSI 3.43
- CORT 2.36
- MACD
- MKSI 1.25
- CORT 0.14
- Stochastic Oscillator
- MKSI 91.16
- CORT 29.58
About MKSI MKS Instruments Inc.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.